Floatz logo

Aadvac1

Progressive Supranuclear Palsy

Adam BoxervaccinePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Progressive Supranuclear Palsy cohort.

Asset / SponsorPhaseRating
Ioflupane
GE Healthcare
Phase 3BB
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BB
Riluzole
King's College London
Phase 3B
[18F]MNI-958
Invicro
Phase 1B
Droxidopa
Loma Linda University
Phase 2CCC

View all 24 →

Same molecule, other indications

Aadvac1 is also rated in:

Alzheimer diseaseActive
CCC
Indicative · Phase 2
55 / 100
View asset →
progressive non-fluent aphasiaDormant
CC
Indicative · Phase 1
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →